EMA Decision Time For Aztreonam-Avibactam; High-Stakes Meeting For Lecanamab

The European Medicines Agency is this week deciding whether a number of new drugs should win EU approval.

Pill capsule with the EU flag. Healthcare in the European Union concept
New drugs could be approved for marketing in the EU soon • Source: Shutterstock

More from Europe

More from Geography